by Team Small News | Jan 12, 2026 | Pharma, Zydus
The Delhi High Court has allowed Zydus Lifesciences to sell and market its biosimilar version of the anti-cancer drug nivolumab in India, despite a patent infringement suit filed by the innovator and patent holder, E.R. Squibb & Sons LLC. The court modified a...
by Team Small News | Dec 20, 2025 | Pharma, Zydus
Zydus Lifesciences Limited, a global life sciences company, has partnered with US-based Myriad Genetics to introduce advanced cancer-risk assessment and prognostic diagnostic tests in India. The exclusive agreement allows Zydus to offer Myriad’s MyRisk...
by Team Small News | Dec 19, 2025 | Pharma, Zydus
Zydus Lifesciences Limited is a global life sciences company based in India that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare therapies. The company operates in the business of integrated pharmaceutical...
by Team Small News | Dec 11, 2025 | Pharma, Zydus
A 45-year-old businessman, Himanshu Dineshbhai Shah, has filed a complaint with the Vastrapur police alleging that he was assaulted by an unidentified Activa rider and traffic police personnel during a roadside altercation near the Zydus Bridge last month. The...
by Team Small News | Dec 5, 2025 | Pharma, Zydus
The U.S. Food and Drug Administration (FDA) has issued an Establishment Inspection Report (EIR) to Zydus Lifesciences, an injectable facility based in Vadodara, India. The report, which was issued with a Voluntary Action Indicated (VAI) classification, is a result of...
by Team Small News | Nov 28, 2025 | Pharma, Zydus
The Taliban-led government in Afghanistan has signed a significant trade agreement with Indian pharmaceutical company Zydus Lifesciences, marking a shift in the country’s trade posture. The $100 million memorandum of understanding was signed between...